ZA200407132B - Chimeric hybrid analgesics - Google Patents
Chimeric hybrid analgesicsInfo
- Publication number
- ZA200407132B ZA200407132B ZA200407132A ZA200407132A ZA200407132B ZA 200407132 B ZA200407132 B ZA 200407132B ZA 200407132 A ZA200407132 A ZA 200407132A ZA 200407132 A ZA200407132 A ZA 200407132A ZA 200407132 B ZA200407132 B ZA 200407132B
- Authority
- ZA
- South Africa
- Prior art keywords
- analgesics
- chimeric hybrid
- chimeric
- hybrid
- hybrid analgesics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/134,187 US6881829B2 (en) | 2002-04-26 | 2002-04-26 | Chimeric hybrid analgesics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200407132B true ZA200407132B (en) | 2006-04-26 |
Family
ID=29249163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200407132A ZA200407132B (en) | 2002-04-26 | 2004-09-07 | Chimeric hybrid analgesics |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US6881829B2 (ru) |
| EP (1) | EP1499335A4 (ru) |
| JP (1) | JP2005523913A (ru) |
| CN (1) | CN1642566A (ru) |
| AU (1) | AU2003228363A1 (ru) |
| BR (1) | BR0309550A (ru) |
| CA (1) | CA2478680A1 (ru) |
| EA (1) | EA008341B1 (ru) |
| IL (2) | IL164033A0 (ru) |
| MX (1) | MXPA04009094A (ru) |
| WO (1) | WO2003090697A2 (ru) |
| ZA (1) | ZA200407132B (ru) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
| US7169752B2 (en) * | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
| US20060014697A1 (en) * | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
| US6881829B2 (en) * | 2002-04-26 | 2005-04-19 | Chimeracom, L.L.C. | Chimeric hybrid analgesics |
| PT1583562E (pt) * | 2003-01-06 | 2011-09-19 | Angiochem Inc | Angiopep-1, compostos relacionados, e suas utilizações |
| DK2433653T3 (da) | 2005-07-15 | 2019-08-19 | Angiochem Inc | Anvendelse af aprotininpolypeptider som bærere i farmaceutiske konjugater |
| AU2007238625A1 (en) * | 2006-04-14 | 2007-10-25 | Shire Llc | Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse |
| US8026218B2 (en) * | 2006-04-26 | 2011-09-27 | The University Of Arizona | Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists |
| US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| EP2279008B1 (en) | 2008-04-18 | 2019-03-06 | Angiochem Inc. | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| US8551939B2 (en) * | 2008-06-03 | 2013-10-08 | Instytut Medycyny Doswiadczalnej I Klinicznej | Peptide analogues, particularly for the treatment of chronic pain |
| JP2012505637A (ja) | 2008-10-15 | 2012-03-08 | アンジオケム，インコーポレーテッド | Ｇｌｐ−１アゴニストのコンジュゲート及びその使用 |
| AU2009304505A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Etoposide and doxorubicin conjugates for drug delivery |
| CN102307904A (zh) | 2008-12-05 | 2012-01-04 | 安吉奥开米公司 | 神经降压素或神经降压素类似物的缀合物及其用途 |
| CN102300987A (zh) | 2008-12-17 | 2011-12-28 | 安吉奥开米公司 | 膜型-1基质金属蛋白抑制剂及其用途 |
| US9173891B2 (en) | 2009-04-20 | 2015-11-03 | Angiochem, Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
| RU2012103240A (ru) | 2009-07-02 | 2013-08-10 | Ангиокем Инк. | Мультимерные пептидные конъюгаты и их применение |
| US20120083452A1 (en) * | 2010-09-30 | 2012-04-05 | Perricone Nicholas V | Topical Anesthetic Uses of Szeto-Schiller Peptides |
| JP6284471B2 (ja) | 2011-05-18 | 2018-02-28 | メデリス ダイアビーティーズ，エルエルシー | インスリン抵抗性のための改善されたペプチドの調合薬 |
| JP6148228B2 (ja) | 2011-05-18 | 2017-06-14 | ユーメデリス ファーマシューティカルズ，インク． | 改善されたペプチド製剤 |
| WO2013056096A1 (en) * | 2011-10-13 | 2013-04-18 | Angiochem Inc. | Polypeptide-opioid conjugates and uses thereof |
| US9687561B2 (en) | 2012-08-14 | 2017-06-27 | Angiochem Inc. | Peptide-dendrimer conjugates and uses thereof |
| WO2014081864A1 (en) * | 2012-11-20 | 2014-05-30 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
| KR102213907B1 (ko) | 2012-11-20 | 2021-02-09 | 메더리스 다이어비티즈, 엘엘씨 | 인슐린 저항성에 대한 개선된 펩티드 약제 |
| US11141452B2 (en) | 2014-02-24 | 2021-10-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain |
| CN117180445A (zh) | 2014-05-28 | 2023-12-08 | 梅德瑞斯糖尿病有限责任公司 | 针对胰岛素抵抗的改良肽药物 |
| CA2968703A1 (en) * | 2015-05-19 | 2016-11-24 | Joseph Robert Knight | Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids |
| ES2826827T3 (es) | 2015-06-15 | 2021-05-19 | Angiochem Inc | Métodos para el tratamiento de carcinomatosis leptomeníngea |
| CA3086918A1 (en) | 2018-01-03 | 2019-07-11 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals for treatment of nash and other disorders |
| WO2023215335A1 (en) * | 2022-05-03 | 2023-11-09 | Lucy Scientific Discovery | Functionalized psychoactive compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891842A (en) | 1993-04-09 | 1999-04-06 | Trustees Of Tufts College | Methodology for eliciting an analgesic response in a living subject |
| PT711289E (pt) * | 1993-07-30 | 2001-02-28 | Delta Pharmaceuticals Inc | Compostos piperazina utilizados em terapia |
| GB9514417D0 (en) * | 1995-07-14 | 1995-09-13 | Iaf Biochem Int | Novel heterocyclic compounds for the treatment of pain and use thereof |
| AUPN603895A0 (en) | 1995-10-19 | 1995-11-09 | University Of Queensland, The | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids |
| UA48219C2 (ru) * | 1996-03-25 | 2002-08-15 | Елі Ліллі Енд Компані | Болеутоляющая композиция (варианты) и способ подавления боли |
| AU724326B2 (en) * | 1996-09-09 | 2000-09-14 | Zealand Pharmaceuticals A/S | Peptide prodrugs containing an alpha-hydroxyacid linker |
| US6063758A (en) | 1997-07-09 | 2000-05-16 | Advanced Targeting Systems, Inc. | Substance P-Saporin (SP-SAP) conjugates and methods of use thereof |
| IL138214A0 (en) * | 1998-03-09 | 2001-10-31 | Zealand Pharmaceuticals As | Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| US6759520B1 (en) | 1999-10-28 | 2004-07-06 | The New England Medical Center Hospitals, Inc. | Chimeric analgesic peptides |
| US6881829B2 (en) * | 2002-04-26 | 2005-04-19 | Chimeracom, L.L.C. | Chimeric hybrid analgesics |
-
2002
- 2002-04-26 US US10/134,187 patent/US6881829B2/en not_active Expired - Fee Related
-
2003
- 2003-03-24 CN CNA038064421A patent/CN1642566A/zh active Pending
- 2003-03-24 EA EA200401106A patent/EA008341B1/ru unknown
- 2003-03-24 MX MXPA04009094A patent/MXPA04009094A/es active IP Right Grant
- 2003-03-24 BR BRPI0309550-9A patent/BR0309550A/pt not_active IP Right Cessation
- 2003-03-24 AU AU2003228363A patent/AU2003228363A1/en not_active Abandoned
- 2003-03-24 CA CA002478680A patent/CA2478680A1/en not_active Abandoned
- 2003-03-24 JP JP2003587336A patent/JP2005523913A/ja active Pending
- 2003-03-24 EP EP03726111A patent/EP1499335A4/en not_active Ceased
- 2003-03-24 WO PCT/US2003/009137 patent/WO2003090697A2/en active Search and Examination
- 2003-10-17 US US10/688,741 patent/US20040106636A1/en not_active Abandoned
- 2003-11-06 IL IL16403303A patent/IL164033A0/xx unknown
- 2003-11-20 US US10/720,039 patent/US7214657B2/en not_active Expired - Fee Related
-
2004
- 2004-09-07 ZA ZA200407132A patent/ZA200407132B/xx unknown
- 2004-09-12 IL IL164033A patent/IL164033A/en not_active IP Right Cessation
- 2004-12-29 US US11/025,494 patent/US20050203016A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6881829B2 (en) | 2005-04-19 |
| CN1642566A (zh) | 2005-07-20 |
| US20030202981A1 (en) | 2003-10-30 |
| US20050203016A1 (en) | 2005-09-15 |
| WO2003090697A2 (en) | 2003-11-06 |
| WO2003090697B1 (en) | 2004-11-18 |
| EP1499335A2 (en) | 2005-01-26 |
| IL164033A0 (en) | 2005-12-18 |
| WO2003090697A3 (en) | 2004-10-07 |
| JP2005523913A (ja) | 2005-08-11 |
| AU2003228363A1 (en) | 2003-11-10 |
| BR0309550A (pt) | 2007-03-13 |
| EP1499335A4 (en) | 2006-11-02 |
| US20040106636A1 (en) | 2004-06-03 |
| EA200401106A1 (ru) | 2005-12-29 |
| IL164033A (en) | 2009-11-18 |
| CA2478680A1 (en) | 2003-11-06 |
| MXPA04009094A (es) | 2004-12-06 |
| EA008341B1 (ru) | 2007-04-27 |
| US20040259786A1 (en) | 2004-12-23 |
| US7214657B2 (en) | 2007-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164033A0 (en) | Chimeric hybrid analgesics | |
| AU158076S (en) | Charger | |
| AU158077S (en) | Charger | |
| EP1557931A4 (en) | MOTOR-GENERATOR | |
| TW551736U (en) | Charger | |
| AU2570P (en) | Sunminbu Hesperozygis hybrid | |
| AU2920P (en) | Sunnicobu Nierembergia hybrid | |
| AU2921P (en) | Sunnikoho Nierembergia hybrid | |
| AU2656P (en) | Balangimpu Angelonia hybrid | |
| AU3065P (en) | Balangpili Angelonia hybrid | |
| AU2658P (en) | Balangdepi Angelonia hybrid | |
| AU2657P (en) | Balanglapi Angelonia hybrid | |
| AU2659P (en) | Balangimla Angelonia hybrid | |
| AU3039P (en) | Sunreniva Torenia hybrid | |
| AU2588P (en) | Conlen Rhododendron hybrid | |
| AU2589P (en) | Conleo Rhododendron hybrid | |
| GB0227316D0 (en) | Electric motor-generators | |
| AU2193P (en) | Q197 Saccharum hybrid | |
| AU2194P (en) | Q198 Saccharum hybrid | |
| AU2195P (en) | Q199 Saccharum hybrid | |
| AU2320P (en) | Q207 Saccharum hybrid | |
| AU2192P (en) | Q196 Saccharum hybrid | |
| GB0206448D0 (en) | Analgesics | |
| AU2781P (en) | KLEC00066 Calibrachoa hybrid | |
| AU2782P (en) | Sunbelkufepi Calibrachoa hybrid |